U.S. Medical Equipment Stock News

NasdaqGS:VCTR
NasdaqGS:VCTRCapital Markets

3 Growth Stocks With High Insider Ownership To Watch Now

Over the last 7 days, the United States market has remained flat, yet it has experienced an impressive 18% rise over the past year, with earnings forecasted to grow by 16% annually. In such a climate, growth companies with high insider ownership can be particularly appealing as they often indicate strong confidence from those who know the business best.
OTCPK:TSPH
OTCPK:TSPHTransportation

3 Penny Stocks With Market Caps Larger Than $40M To Watch

The market remained flat over the last week, yet it is up 18% over the past year, with earnings forecast to grow by 16% annually. Investing in penny stocks—often smaller or newer companies—can still open doors to growth opportunities, particularly when these stocks are backed by strong financial health. This article explores several penny stocks that offer compelling opportunities with less risk than one might expect, showcasing above-average balance sheet resilience.
NYSE:OHI
NYSE:OHIHealth Care REITs

Best Dividend Stocks For August 2026

The United States market remained flat over the last week, but it has risen 18% over the past year with earnings forecasted to grow by 16% annually. In this environment, identifying strong dividend stocks can be an effective strategy for investors seeking stable income and potential capital appreciation.
NasdaqGM:IESC
NasdaqGM:IESCConstruction

IES Holdings (IESC) Posted Strong Q3 Growth, Is The Upside Already Priced In?

Why the latest IES Holdings earnings matter for investors IES Holdings (IESC) posted third quarter 2026 results on July 31, with sales of $1,242.7 million and net income of $152.97 million. Earnings per share also rose compared with the prior year. For the first nine months of 2026, IES Holdings reported sales of $3,087.94 million and net income of $354.32 million. Basic and diluted earnings per share from continuing operations were higher than the same period in 2025. See our latest analysis...
NYSE:AMN
NYSE:AMNHealthcare

3 US Defensive Stocks Built For Inflation And Rate Uncertainty

With inflation still running above the Fed’s 2% target and rate expectations shifting with every new comment from policymakers, many investors are rethinking how to position their portfolios. Defensive sector stocks can sometimes offer a steadier ride when interest rates and bond yields are in focus, because these companies sell essential goods and services that people tend to keep buying. This article looks at three U.S. defensive stocks that are closely exposed to the latest Federal Reserve...
NYSE:SXT
NYSE:SXTChemicals

Is Sensient Technologies (SXT) Undervalued As Strong Q2 Results And Higher Guidance Lift Confidence?

Why Sensient Technologies Stock Is Back In Focus After Q2 Earnings Sensient Technologies (SXT) is on investors radar after reporting second quarter 2026 results alongside updated full year guidance and a fresh confirmation of its regular cash dividend. The company reported second quarter sales of US$462.08 million and net income of US$51.36 million, compared with US$414.23 million and US$37.59 million a year earlier. Diluted EPS from continuing operations was US$1.20 versus US$0.88. For the...
NasdaqGM:IRON
NasdaqGM:IRONBiotechs

Is Disc Medicine (IRON) Undervalued As Q2 Losses Widen?

Q2 2026 results highlight ongoing losses and cash burn Disc Medicine (IRON) released second quarter and first half 2026 results on July 30, 2026, giving investors a fresh look at the company’s cash burn and earnings profile. For the second quarter, Disc Medicine reported a net loss of US$59.53 million compared with US$55.25 million a year earlier. Basic loss per share from continuing operations was US$1.54 compared with US$1.58 a year ago, which points to a slightly smaller per share loss...
NasdaqGS:NWL
NasdaqGS:NWLConsumer Durables

Newell Brands (NWL) Beat Expectations, Is The Stock Now Fully Priced?

Newell Brands (NWL) has just paired stronger second quarter earnings with a higher full year sales growth outlook and a new US$800 million asset based revolving credit facility, drawing fresh attention to the stock. See our latest analysis for Newell Brands. The latest earnings beat, higher sales outlook and new US$800 million credit facility appear to have shifted sentiment toward Newell Brands, with a 1-day share price return of 8.95% and a year-to-date share price return of 50.54%...
NYSE:HLI
NYSE:HLICapital Markets

Houlihan Lokey (HLI) Leads North American M And A Volume, Is It Still 19% Undervalued?

Houlihan Lokey (HLI) has been recognized as the leading M&A adviser by deal volume in North America for the first half of 2026, highlighting its role across a wide range of client transactions. See our latest analysis for Houlihan Lokey. Despite Houlihan Lokey’s leading M&A role, the stock has faced pressure, with the share price down 10.51% over the past week and 28.84% year to date. However, the 5-year total shareholder return of 58.27% reflects a stronger longer-term picture. After recent...
NasdaqGS:MDGL
NasdaqGS:MDGLBiotechs

Is Madrigal Pharmaceuticals (MDGL) Undervalued After Wider Losses In Its Second Quarter Results?

Madrigal Pharmaceuticals (MDGL) drew fresh attention on July 30, 2026, after reporting second quarter and six month results that showed wider net losses compared with the same periods a year earlier. See our latest analysis for Madrigal Pharmaceuticals. The latest results have coincided with pressure on Madrigal Pharmaceuticals' share price, which closed at $467.32 after falling 5.23% on the day and 14.18% over the past week. However, the 1 year total shareholder return of 54.65% points to...
NasdaqGS:ZBRA
NasdaqGS:ZBRAElectronic

Zebra Technologies (ZBRA) Is Up 11.0% After Raising Guidance On Strong Quarter - What's Changed

Zebra Technologies Corporation recently reported quarterly results that exceeded analysts’ revenue and earnings expectations and raised guidance, following a 14.3% year-on-year revenue increase in the prior period. With the market now expecting revenue to grow 15.9% year on year this quarter, investor attention has intensified around whether Zebra can sustain its recent operational momentum. Next, we’ll examine how these stronger-than-expected results and upbeat revenue expectations might...
NasdaqGS:ARCB
NasdaqGS:ARCBTransportation

Why ArcBest (ARCB) Is Down 6.4% After Posting a GAAP Loss Despite Higher Sales and Tech Push

In the past quarter, ArcBest Corporation reported second-quarter 2026 sales of US$1,184.53 million, up from US$1,022.26 million a year earlier, but shifted from a net income of US$25.81 million to a net loss of US$13.82 million, while continuing share repurchases and affirming a US$0.12 quarterly dividend. Despite the headline GAAP loss, ArcBest’s improved asset-based operating ratio, non-GAAP profit beat, restructuring efforts, and launch of its ArcBestView digital logistics platform...
NYSE:BH.A
NYSE:BH.AHospitality

Is Biglari Holdings (BH.A) Undervalued After Its Recent Rally?

Biglari Holdings stock performance snapshot Biglari Holdings (BH.A) has drawn investor attention after recent share price moves, with the stock last closing at US$1,984.54. Returns show mixed short term performance, with a decline over the past month but gains over the past 3 months. See our latest analysis for Biglari Holdings. For context, Biglari Holdings has seen its share price pull back over the past month, even after a strong 3 month share price return of 28.42% and a 1 year total...
NasdaqGS:GEHC
NasdaqGS:GEHCMedical Equipment

GE HealthCare Technologies (GEHC) Is Up 12.3% After Dense-Breast Imaging Launch And CFO Transition News

GE HealthCare Technologies recently reported its second-quarter 2026 results, showing higher revenue of US$5,295 million and net income of US$561 million year over year, while also completing a US$500 million share repurchase program, announcing a review of its challenged Patient Care Solutions unit, and managing a planned CFO transition. A key development is the launch of the Invenia ABUS Prime and ABUS StreamVue breast imaging systems, both cleared in the US and Europe, which broadens GE...
NasdaqGS:PTCT
NasdaqGS:PTCTBiotechs

PTC Therapeutics (PTCT) Is Down 11.5% After Raising 2026 Outlook And Boosting Profitability - Has The Bull Case Changed?

PTC Therapeutics reported second-quarter 2026 revenue of US$360.52 million and net income of US$83.5 million, and raised its full-year 2026 revenue outlook to between US$1.18 billion and US$1.28 billion, while also appointing long-serving human resources executive Hege Sollie-Zetlmayer to its board. An interesting angle is that the company’s strong quarterly profit contrasts with lower year-to-date revenue versus the prior year, raising questions about how its earnings quality and business...
NYSE:BFH
NYSE:BFHConsumer Finance

How Bread Financial’s Q2 2026 Capital Return Moves May Impact Bread Financial Holdings (BFH) Investors

Bread Financial Holdings, Inc. reported second-quarter 2026 results with net interest income of US$1,039 million and net income of US$146 million, while also completing a buyback of 7,343,098 shares for US$551.36 million and declaring a quarterly dividend of US$0.23 per share payable on September 15, 2026. The combination of higher earnings per share, a large completed repurchase that reduced the share count, and continued cash returns through dividends underscores management’s ongoing focus...
NasdaqGS:PI
NasdaqGS:PISemiconductor

3 US Stocks Built For Tariff Driven Supply Chain Shifts

The latest round of Section 301 and Section 338 tariffs is prompting investors to reconsider how exposed portfolios are to complex global supply chains. Higher duties, extra compliance checks and uncertain trade rules can all squeeze margins or re-route production closer to home. That is where a curated US manufacturing and onshoring screener can help focus attention. It filters for larger, financially healthy companies with operations rooted in North America. In this article, you will see...
NYSE:SPHR
NYSE:SPHREntertainment

The Bull Case For Sphere Entertainment (SPHR) Could Change Following Mixed Q2 Results And Aggressive Expansion Plans

Sphere Entertainment Co. has reported past second-quarter 2026 results showing sales of US$313.64 million versus US$282.68 million a year earlier, alongside a shift from net income of US$151.82 million to a net loss of US$38.79 million. Despite reporting a loss, the company highlighted growing Sphere-driven revenue, venue expansion plans in Abu Dhabi and National Harbor, and a broader content slate including future Wizard of Oz and Rocky Horror Picture Show experiences. We will now examine...
NYSE:FTI
NYSE:FTIEnergy Services

TechnipFMC (FTI) Reaffirms Guidance As Strong Results Keep Undervalued Narrative Alive

TechnipFMC (FTI) is back in focus after reporting higher second quarter and first half 2026 revenue and net income compared with last year, while also reaffirming full year revenue guidance for its Subsea and Surface Technologies segments. See our latest analysis for TechnipFMC. TechnipFMC’s results and reaffirmed guidance come after a strong run, with the share price delivering a 51.47% year to date share price return and a very large 5 year total shareholder return. This is despite the 7...
NYSE:HAYW
NYSE:HAYWBuilding

Will Strong Q2 Results and M&A Ambitions Change Hayward Holdings' (HAYW) Capital Allocation Narrative?

In late July 2026, Hayward Holdings reported second-quarter 2026 results showing higher sales and net income year over year, reaffirmed its full-year 2026 outlook for approximately US$200 million in free cash flow, and highlighted low leverage, ample liquidity, and plans to pursue acquisitions alongside returning capital to shareholders. The combination of revenue outperformance, stable guidance, and an explicit intention to use strong cash generation to fund both organic investment and...
NasdaqGS:TRS
NasdaqGS:TRSPackaging

The Bull Case For TriMas (TRS) Could Change Following Upbeat Guidance And Capital Return Push - Learn Why

TriMas Corporation’s recent second-quarter and six-month 2026 results showed slightly higher sales of US$174.58 million and US$342.86 million respectively, alongside lower quarterly net income of US$13.37 million but a very large six‑month net income of US$814.2 million, while continuing its share repurchase program and affirming a US$0.0400 quarterly dividend. Beneath the headline numbers, the combination of improved profitability from continuing operations, a long-running buyback that has...
NYSE:SAH
NYSE:SAHSpecialty Retail

Does Sonic Automotive’s (SAH) Profit Return and Ongoing Buybacks Reveal Its Core Capital Allocation Bet?

Sonic Automotive, Inc. reported past second-quarter 2026 results with revenue of US$3,934.0 million and net income of US$57.4 million, completing another US$6.82 million share buyback tranche and affirming a US$0.41 per-share dividend. The swing from a prior-year quarterly net loss to profit, alongside long-running buybacks totaling about US$1.29 billion, highlights management’s ongoing emphasis on shareholder returns and operational improvement. We’ll now examine how this return to...
NYSE:EE
NYSE:EEOil and Gas

Excelerate Energy (EE) Lifts Dividend As Fair Value Still Sits Higher

Excelerate Energy (EE) is back in focus after its board approved a quarterly cash dividend of $0.09 per Class A share for the June 2026 quarter, representing a 13% increase from the prior payout. See our latest analysis for Excelerate Energy. Excelerate Energy’s recent dividend decision comes after a strong run in the stock, with a 90-day share price return of about 13.9% and a year to date share price return of 38.6%. The 1 year total shareholder return sits above 55%, signaling firm...
NYSE:JXN
NYSE:JXNDiversified Financial

Is Jackson Financial (JXN) Below Fair Value On Its CEO And CFO Transition?

Jackson Financial (JXN) is entering a planned leadership transition that will place longtime finance executive Don W. Cummings in the Chief Executive Officer role and elevate Brian M. Walta to Chief Financial Officer. See our latest analysis for Jackson Financial. Jackson Financial’s leadership reshuffle arrives during a period of strong stock momentum, with a 30 day share price return of 16.98%, year to date share price return of 13.79%, and a 1 year total shareholder return of 50.40%,...